Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Genomic Factors for Prognosis of AIDS Primary Effusion Lymphoma

NCT02823327 is registered in ClinicalTrials.gov with AIDS Malignancy Consortium as lead sponsor.

NCT NCT02823327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02823327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Genomic Factors for Prognosis of AIDS Primary Effusion Lymphoma
Lead sponsor
AIDS Malignancy Consortium
Phase
Observational
Overall status
Terminated
Start date
October 11, 2016
Completion date
February 3, 2023
Enrollment
25 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

aids-related primary effusion lymphoma